Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1974 Oct;180(4):558–565. doi: 10.1097/00000658-197410000-00020

The Influence of Total Gastrectomy on Survival in Malignant Zollinger-Ellison Tumors

Paul S Fox, James W Hofmann, Jerome J Decosse, Stuart D Wilson
PMCID: PMC1344141  PMID: 4416322

Abstract

The effect of total gastrectomy on the biologic behavior of malignant gastrinomas was studied from patient data collected in the ZE tumor registry. A total of 267 patients with documented metastatic tumor had definitive gastric operations. In the 137 patients who had total gastrectomy, survival was 75% at one year, 55% at five years and 42% at ten years. In the 130 patients who had lesser gastric operations, survival was 51% at one year, 27% at five years and 18% at ten years. Deaths from progressive tumor growth occurred in 17% of the patients at risk after total gastrectomy and 30% of the patients at risk after lesser gastric operations. A subgroup of 127 patients with documented liver metastasis had definitive gastric operations. Seventythree patients with liver metastasis had total gastrectomy with survival of 68% at one year, 42% at five years and 30% at ten years. Fifty-four patients with liver metastasis had lesser gastric operations with survival of 44% at one year, 7% at five years and none at ten years. Deaths from progressive tumor growth occurred in 25% of the patients at risk after total gastrectomy and 50% of the patients at risk after lesser gastric operations. Regression of metastatic ZE tumor was clearly documented in only four patients; all had total gastrectomy. Presumptive regression of primary tumor occurred in seven patients, five had total gastrectomy. The study clearly demonstrated that total gastrectomy was the procedure of choice for malignant ZE tumors, even in the presence of widespread metastasis. The results provided indirect evidence to support a gastric feedback effect which influences growth of gastrinomas; however, the results also show that total gastrectomy furnished neither predictable nor permanent protection from subsequent tumor growth and metastasis.

Full text

PDF
558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cameron A. J., Hoffman H. N., 2nd Zollinger-Ellison syndrome. Clinical features and long-term follow-up. Mayo Clin Proc. 1974 Jan;49(1):44–51. [PubMed] [Google Scholar]
  2. ELLISON E. H., WILSON S. D. THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES. Ann Surg. 1964 Sep;160:512–530. doi: 10.1097/00000658-196409000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox P. S., Hofmann J. W., Wilson S. D., DeCosse J. J. Surgical management of the Zollinger-Ellison syndrome. Surg Clin North Am. 1974 Apr;54(2):395–407. doi: 10.1016/s0039-6109(16)40287-2. [DOI] [PubMed] [Google Scholar]
  4. Friesen S. R. A gastric factor in the pathogenesis of the Zollinger-Ellison syndrome. Ann Surg. 1968 Sep;168(3):483–501. doi: 10.1097/00000658-196809000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Friesen S. R. Effect of total gastrectomy on the Zollinger-Ellison tumor: observations by second-look procedures. Surgery. 1967 Oct;62(4):609–613. [PubMed] [Google Scholar]
  6. MELNYK C. S., KRIPPAEHNE W. W., BENSON J. A., Jr, DUNPHY J. E. SPONTANEOUS REMISSION OF ZOLLINGER-ELLISON SYNDROME. Arch Intern Med. 1965 Jan;115:42–47. doi: 10.1001/archinte.1965.03860130044007. [DOI] [PubMed] [Google Scholar]
  7. Passaro E., Jr, Basso N., Sanchez R. E., Gordon H. E. New studies in the Zollinger-Ellison syndrome. Am J Surg. 1970 Aug;120(2):138–143. doi: 10.1016/s0002-9610(70)80101-5. [DOI] [PubMed] [Google Scholar]
  8. Passaro E., Jr, Gordon H. E. Proceedings: Malignant gastrinoma following total gastrectomy. Arch Surg. 1974 Apr;108(4):444–448. doi: 10.1001/archsurg.1974.01350280050009. [DOI] [PubMed] [Google Scholar]
  9. Sanzenbacher L. J., King D. R., Zollinger R. M. Prognostic implications of calcium-mediated gastrin levels in the ulcerogenic syndrome. Am J Surg. 1973 Jan;125(1):116–121. doi: 10.1016/0002-9610(73)90015-9. [DOI] [PubMed] [Google Scholar]
  10. Smalley R. S., Wilde H. Ulcerogenic tumor, a case report. Alaska Med. 1968 Mar;10(1):28–31. [PubMed] [Google Scholar]
  11. Thompson J. C., Reeder D. D., Bunchman H. H. Clinical role of serum gastrin measurements in the Zollinger-Ellison syndrome. Am J Surg. 1972 Aug;124(2):250–261. doi: 10.1016/0002-9610(72)90022-0. [DOI] [PubMed] [Google Scholar]
  12. Wilson S. D., Ellison E. H. Survival in patients with the Zollinger-Ellison syndrome treated by total gastrectomy. Am J Surg. 1966 Jun;111(6):787–791. doi: 10.1016/0002-9610(66)90173-5. [DOI] [PubMed] [Google Scholar]
  13. Wilson S. D., Schulte W. J., Meade R. C. Longevity studies following total gastrectomy. In children with the Zollinger-Ellison syndrome. Arch Surg. 1971 Aug;103(2):108–115. doi: 10.1001/archsurg.1971.01350080024003. [DOI] [PubMed] [Google Scholar]
  14. ZOLLINGER R. M., ELLISON E. H. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 1955 Oct;142(4):709-23; discussion, 724-8. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES